Report cover image

Psoriatic Arthritis Therapeutics Drug Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 124 Pages
SKU # APRC20352063

Description

Summary

According to APO Research, the global Psoriatic Arthritis Therapeutics Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Psoriatic Arthritis Therapeutics Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Psoriatic Arthritis Therapeutics Drug include Novartis, Eli Lilly, Pfizer, Amgen, AbbVie, UCB, Janssen Biotech, CELGENE CORPORATION and Bristol-Myers Squibb, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics Drug.

The report will help the Psoriatic Arthritis Therapeutics Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Psoriatic Arthritis Therapeutics Drug market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Psoriatic Arthritis Therapeutics Drug Segment by Company

Novartis
Eli Lilly
Pfizer
Amgen
AbbVie
UCB
Janssen Biotech
CELGENE CORPORATION
Bristol-Myers Squibb
Biogen
Psoriatic Arthritis Therapeutics Drug Segment by Type

Interleukin Inhibitors
NF Inhibitors
PDE4 Inhibitors
Others
Psoriatic Arthritis Therapeutics Drug Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Psoriatic Arthritis Therapeutics Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psoriatic Arthritis Therapeutics Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Psoriatic Arthritis Therapeutics Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psoriatic Arthritis Therapeutics Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Psoriatic Arthritis Therapeutics Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Psoriatic Arthritis Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

124 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size (2020-2031)
2.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales (2020-2031)
2.2.3 Global Psoriatic Arthritis Therapeutics Drug Market Average Price (2020-2031)
2.3 Psoriatic Arthritis Therapeutics Drug by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Interleukin Inhibitors
2.3.3 NF Inhibitors
2.3.4 PDE4 Inhibitors
2.3.5 Others
2.4 Psoriatic Arthritis Therapeutics Drug by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
3.1 Global Psoriatic Arthritis Therapeutics Drug Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Psoriatic Arthritis Therapeutics Drug Sales (W Units) of Manufacturers (2020-2025)
3.3 Global Psoriatic Arthritis Therapeutics Drug Revenue of Manufacturers (2020-2025)
3.4 Global Psoriatic Arthritis Therapeutics Drug Average Price by Manufacturers (2020-2025)
3.5 Global Psoriatic Arthritis Therapeutics Drug Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Type & Application
3.8 Global Manufacturers of Psoriatic Arthritis Therapeutics Drug, Established Date
3.9 Global Psoriatic Arthritis Therapeutics Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Novartis
4.1.1 Novartis Company Information
4.1.2 Novartis Business Overview
4.1.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.1.5 Novartis Recent Developments
4.2 Eli Lilly
4.2.1 Eli Lilly Company Information
4.2.2 Eli Lilly Business Overview
4.2.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.2.5 Eli Lilly Recent Developments
4.3 Pfizer
4.3.1 Pfizer Company Information
4.3.2 Pfizer Business Overview
4.3.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.3.5 Pfizer Recent Developments
4.4 Amgen
4.4.1 Amgen Company Information
4.4.2 Amgen Business Overview
4.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.4.5 Amgen Recent Developments
4.5 AbbVie
4.5.1 AbbVie Company Information
4.5.2 AbbVie Business Overview
4.5.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.5.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.5.5 AbbVie Recent Developments
4.6 UCB
4.6.1 UCB Company Information
4.6.2 UCB Business Overview
4.6.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.6.4 UCB Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.6.5 UCB Recent Developments
4.7 Janssen Biotech
4.7.1 Janssen Biotech Company Information
4.7.2 Janssen Biotech Business Overview
4.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.7.5 Janssen Biotech Recent Developments
4.8 CELGENE CORPORATION
4.8.1 CELGENE CORPORATION Company Information
4.8.2 CELGENE CORPORATION Business Overview
4.8.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.8.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.8.5 CELGENE CORPORATION Recent Developments
4.9 Bristol-Myers Squibb
4.9.1 Bristol-Myers Squibb Company Information
4.9.2 Bristol-Myers Squibb Business Overview
4.9.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.9.5 Bristol-Myers Squibb Recent Developments
4.10 Biogen
4.10.1 Biogen Company Information
4.10.2 Biogen Business Overview
4.10.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Portfolio
4.10.5 Biogen Recent Developments
5 Global Psoriatic Arthritis Therapeutics Drug Market Scenario by Region
5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2020-2031
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2020-2025
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2026-2031
5.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2020-2031
5.3.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2020-2025
5.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2026-2031
5.4 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
5.4.1 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2020-2031)
5.4.3 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
5.5.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2020-2031)
5.5.3 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Country (2020-2031)
5.6.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
5.7.1 South America Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Psoriatic Arthritis Therapeutics Drug Sales by Country (2020-2031)
5.7.3 South America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.7.7 Colombia
5.8 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2020-2031)
5.8.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2020-2031)
6.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2020-2031) & (W Units)
6.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2020-2031)
6.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2020-2031)
6.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2020-2031)
6.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2020-2031)
7 Segment by Application
7.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2020-2031)
7.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2020-2031) & (W Units)
7.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2020-2031)
7.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2020-2031)
7.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2020-2031)
7.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Psoriatic Arthritis Therapeutics Drug Value Chain Analysis
8.1.1 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
8.2 Psoriatic Arthritis Therapeutics Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Psoriatic Arthritis Therapeutics Drug Distributors
8.2.3 Psoriatic Arthritis Therapeutics Drug Customers
9 Global Psoriatic Arthritis Therapeutics Drug Analyzing Market Dynamics
9.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
9.2 Psoriatic Arthritis Therapeutics Drug Industry Drivers
9.3 Psoriatic Arthritis Therapeutics Drug Industry Opportunities and Challenges
9.4 Psoriatic Arthritis Therapeutics Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.